Renovaro inc. proudly announces the appointment of professor dr. geert kazemier as the chairman of its scientific advisory board, a move that heralds a new era of innovation and progress in its mission to reshape cancer screening, diagnosis, and patient care

Los angeles and amsterdam, april 18, 2024 (globe newswire) -- renovaro inc. (nasdaq: renb), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, announces the distinguished professor geert kazemier, md, phd, as the new chairman of its scientific advisory board. this pivotal move signifies a major leap forward in renovaro's quest to redefine cancer diagnosis and treatment through cutting-edge ai and immunotherapy technologies.
RENB Ratings Summary
RENB Quant Ranking